BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
BLFS on Nasdaq
Shares outstanding
47,970,593
Price per share
$24.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
48,107,711
Total reported value
$1,227,205,552
% of total 13F portfolios
0%
Share change
-1,632,179
Value change
-$40,341,783
Number of holders
188
Price from insider filings
$24.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 12% -11% $151,967,279 -$19,132,500 5,957,165 -11% Casdin Capital, LLC 15 Oct 2025
T. Rowe Price Investment Management, Inc. 11% +21% $125,272,324 +$22,586,973 5,180,824 +22% T. Rowe Price Investment Management, Inc. 31 Dec 2025

As of 30 Sep 2025, 188 institutional investors reported holding 48,107,711 shares of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS). This represents 100% of the company’s total 47,970,593 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) together control 81% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 14% 6,707,165 -13% 14% $171,099,779
BlackRock, Inc. 12% 5,600,498 +1.1% 0% $142,868,705
T. Rowe Price Investment Management, Inc. 8.5% 4,066,852 -4.2% 0.06% $103,746,000
Invesco Ltd. 7.5% 3,599,444 +0.52% 0.01% $91,821,818
VANGUARD GROUP INC 6.2% 2,967,518 +2.4% 0% $75,701,384
STATE STREET CORP 3% 1,456,565 +3.4% 0% $37,156,973
FRED ALGER MANAGEMENT, LLC 2.3% 1,108,922 -11% 0.11% $28,288,600
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.3% 1,097,352 -0.43% 0.01% $27,993,449
FMR LLC 2.1% 1,015,771 +32869% 0% $25,912,309
Rockefeller Capital Management L.P. 2.1% 1,010,129 -1.6% 0.05% $25,768,391
DIMENSIONAL FUND ADVISORS LP 2.1% 1,003,383 +2.1% 0.01% $25,592,378
GEODE CAPITAL MANAGEMENT, LLC 2% 952,338 +3.4% 0% $24,296,516
ROYAL BANK OF CANADA 1.9% 919,236 +16% 0% $23,450,000
AMERIPRISE FINANCIAL INC 1.9% 908,901 -16% 0.01% $23,186,064
PALISADE CAPITAL MANAGEMENT, LP 1.9% 908,440 -1.2% 0.63% $23,174,304
GENEVA CAPITAL MANAGEMENT LLC 1.9% 899,031 -0.3% 0.39% $22,934,283
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 1.3% 630,591 -1.2% 0.17% $16,086,376
Stephens Investment Management Group LLC 1.3% 608,814 +14% 0.2% $15,530,845
MORGAN STANLEY 1.2% 580,700 +11% 0% $14,813,662
GAGNON SECURITIES LLC 1.1% 535,757 -0.77% 2.7% $13,667,161
Voya Investment Management LLC 1% 497,254 -31% 0.01% $12,684,950
RAYMOND JAMES FINANCIAL INC 1% 480,438 -32% 0% $12,255,961
BANK OF AMERICA CORP /DE/ 1% 478,273 -29% 0% $12,200,745
ROYCE & ASSOCIATES LP 0.98% 471,929 -9.6% 0.12% $12,038,909
Curi Capital, LLC 0.9% 432,124 -3.6% 0.2% $11,023,477

Institutional Holders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,607,663 $38,913,662 +$5,645,798 $24.18 17
2025 Q3 48,107,711 $1,227,205,552 -$40,341,783 $25.51 188
2025 Q2 49,891,551 $1,074,666,783 +$46,085,035 $21.54 193
2025 Q1 47,668,681 $1,088,709,499 +$20,128,588 $22.84 188
2024 Q4 46,805,050 $1,214,970,700 +$32,660,204 $25.96 179
2024 Q3 45,256,383 $1,133,546,998 -$37,704,401 $25.04 193
2024 Q2 46,759,086 $1,001,701,609 +$52,199,509 $21.43 164
2024 Q1 44,406,426 $823,506,297 -$18,755,552 $18.55 148
2023 Q4 45,388,256 $737,705,671 +$37,803,026 $16.25 138
2023 Q3 43,572,418 $601,804,361 +$31,718,369 $13.81 152
2023 Q2 40,574,468 $896,734,819 +$40,556,636 $22.10 155
2023 Q1 38,757,969 $842,823,822 +$17,191,226 $21.75 165
2022 Q4 38,161,776 $694,539,798 -$10,679,652 $18.20 160
2022 Q3 38,421,067 $874,137,954 +$38,798,900 $22.75 169
2022 Q2 36,797,091 $508,323,451 +$12,324,863 $13.81 146
2022 Q1 35,131,386 $798,491,817 -$7,596,956 $22.73 155
2021 Q4 34,958,126 $1,302,914,183 +$115,722,970 $37.27 165
2021 Q3 31,670,115 $1,340,574,104 +$157,430,709 $42.32 159
2021 Q2 27,974,612 $1,245,139,856 +$121,193,958 $44.51 130
2021 Q1 25,413,123 $914,855,472 +$45,084,655 $36.00 130
2020 Q4 24,231,900 $966,664,009 +$97,438,296 $39.89 125
2020 Q3 22,145,073 $640,866,936 +$216,554,424 $28.94 104
2020 Q2 14,927,170 $244,144,153 +$49,280,131 $16.35 82
2020 Q1 12,125,864 $115,194,176 +$10,152,917 $9.50 73
2019 Q4 10,352,922 $167,504,873 -$1,157,792 $16.18 79
2019 Q3 10,248,020 $170,376,845 +$21,192,749 $16.63 78
2019 Q2 8,980,039 $150,448,121 +$6,076,613 $16.95 71
2019 Q1 8,599,553 $153,847,483 +$19,590,648 $17.89 65
2018 Q4 7,525,099 $90,520,000 -$6,348,673 $12.03 52
2018 Q3 7,614,985 $133,259,000 +$55,383,982 $17.50 51
2018 Q2 4,545,796 $51,865,700 +$32,049,888 $11.41 45
2018 Q1 1,683,075 $8,619,000 -$151,371 $5.12 23
2017 Q4 1,709,367 $10,256,000 +$2,569,633 $6.00 26
2017 Q3 1,282,103 $7,324,000 +$5,380,776 $5.71 19
2017 Q2 339,958 $813,000 +$183,536 $2.40 8
2017 Q1 266,914 $557,000 +$91,186 $2.09 8
2016 Q4 266,829 $431,000 -$33,995 $1.60 11
2016 Q3 282,237 $518,000 -$124,588 $1.84 10
2016 Q2 381,436 $609,000 +$39,267 $1.60 9
2016 Q1 356,480 $653,000 +$28,574 $1.83 9
2015 Q4 338,498 $736,000 +$10,054 $2.20 7
2015 Q3 333,970 $707,000 +$93,511 $2.12 6
2015 Q2 290,217 $566,010 -$196,456 $1.95 5
2015 Q1 422,277 $681,008 -$329,999 $1.61 9
2014 Q4 623,246 $1,023,008 -$91,795 $1.64 7
2014 Q3 579,026 $1,216,311 +$668 $2.10 7
2014 Q2 577,808 $1,318,011 +$1,318,011 $2.28 8